General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Astra Zeneca(SIGNIFICANT), Amgen(SIGNIFICANT), Janssen Pharmaceuticals(SIGNIFICANT), Cytokinetics(SIGNIFICANT), Elsevier Publishers(SIGNIFICANT), Signal Path(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Familial Hypercholesterolemia Foundation(SIGNIFICANT), Sanofi-Aventis(SIGNIFICANT), Ferring Pharmaceuticals(SIGNIFICANT), Myokardia(MODEST), Patient Centered Outcomes Research Institute(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Novo Nordisk Inc.(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT)

View Full Disclosure